D'Argento, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 626
EU - Europa 388
AS - Asia 205
AF - Africa 12
SA - Sud America 1
Totale 1.232
Nazione #
US - Stati Uniti d'America 621
SE - Svezia 124
IT - Italia 86
SG - Singapore 77
CN - Cina 72
DE - Germania 35
IE - Irlanda 34
IN - India 26
ID - Indonesia 21
FR - Francia 19
FI - Finlandia 15
RU - Federazione Russa 15
BE - Belgio 14
GB - Regno Unito 13
CI - Costa d'Avorio 12
CZ - Repubblica Ceca 10
IR - Iran 8
UA - Ucraina 6
CA - Canada 4
RO - Romania 4
CH - Svizzera 3
AT - Austria 2
GR - Grecia 2
LT - Lituania 2
NL - Olanda 2
BN - Brunei Darussalam 1
CL - Cile 1
ES - Italia 1
MD - Moldavia 1
MX - Messico 1
Totale 1.232
Città #
Chandler 171
Singapore 58
Ashburn 46
Ann Arbor 33
Dublin 33
Cattolica 32
New York 23
Boardman 21
Jakarta 21
San Mateo 21
Redmond 19
Rome 15
Brussels 14
Wilmington 14
Boston 13
Moscow 13
Abidjan 12
Dearborn 12
Princeton 12
Marseille 11
Shanghai 11
Brno 9
Falls Church 9
Helsinki 9
Jacksonville 9
Milan 9
Bremen 8
Nanjing 8
Los Angeles 7
Falkenstein 5
Lawrence 5
Santa Clara 5
Beijing 4
Fairfield 4
London 4
Redwood City 4
Shenyang 4
Andover 3
Hebei 3
Miami 3
Nanchang 3
Norwalk 3
Seattle 3
Tianjin 3
Toronto 3
Ardabil 2
Augusta 2
Bern 2
Cambridge 2
Frankfurt am Main 2
Jiaxing 2
Kish 2
Leawood 2
Mountain View 2
Munich 2
New Haven 2
Paris 2
San Rafael 2
Vienna 2
Woodbridge 2
Athens 1
Athlone 1
Atlanta 1
Bandar Seri Begawan 1
Brdo 1
Busto Arsizio 1
Cervignano del Friuli 1
Changsha 1
Chennai 1
Chicago 1
Chisinau 1
Chiswick 1
City of London 1
Civitanova Marche 1
Cluj-Napoca 1
Cologne 1
Edinburgh 1
Gavirate 1
Genova 1
Groningen 1
Gunzenhausen 1
Gurgaon 1
Hangzhou 1
Hounslow 1
Houston 1
Hyderabad 1
Jinan 1
Kashan 1
Kilburn 1
Kunming 1
Ladispoli 1
Lancaster 1
Lausanne 1
Mexico City 1
Mumbai 1
Ningbo 1
Nuoro 1
Nuremberg 1
Ottawa 1
Palermo 1
Totale 802
Nome #
Are TKIs favourable for the elderly with non-small-cell lung cancer? 107
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 100
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 84
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 84
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 75
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 74
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 67
Exploring the molecular and biological background of lung neuroendocrine tumours 56
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 56
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 55
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 55
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 54
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 53
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 50
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 49
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 49
Collagenous colitis and atezolizumab therapy: an atypical case. 46
Eficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: Case series and review of the literature 46
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 30
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 28
Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery 22
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 21
Totale 1.261
Categoria #
all - tutte 6.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202058 0 0 0 0 0 2 20 1 3 0 28 4
2020/202154 4 5 2 1 2 1 7 1 6 7 15 3
2021/2022186 26 3 1 29 10 8 2 25 9 6 22 45
2022/2023433 54 54 39 81 29 55 25 32 45 2 10 7
2023/2024217 2 59 5 9 5 23 17 14 3 12 22 46
2024/2025173 23 16 39 38 45 12 0 0 0 0 0 0
Totale 1.261